vialroom
Thread · #tirzepatide · 2024-09-13

the sweet spot argument is really about effect per

Spun off from a message in #tirzepatide on 2024-09-13. 17 messages, 4 participants.

The message this came from
  • swab_dry_first — the sweet spot argument is really about effect per side effect, not a magic number 21:12
DD

does switching from semaglutide need a gap or do you just start

HL

dual agonist, GIP as well as GLP-1, thats the whole difference in one line

DD

switched from 0.5 semaglutide and started at 2.5, took the slow route, never regretted it

DD

is there a reason to titrate slower than the four week schedule

GG

12 did nothing extra over 10 for me and that still holds a year later

SD

the trials titrated every four weeks to a target, most people here stop at whatever works

the sweet spot argument is really about effect per side effect, not a magic number

DD

the sweet spot argument is really about effect per side effect, not a magic number

DD

there is no clean conversion between the two, anyone giving you a ratio is guessing